Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Rico Auto Industries posted a Q1 FY27 consolidated net loss of ₹3.38 crore despite 39% YoY revenue growth, with one-time labour code costs and an unmodified auditor review.
Shree Rama Newsprint & Papers reported a wider June-quarter loss, disclosed total income of ₹11.4 crore and confirmed ZCD redemption, as its board approved unaudited results on August 13, 2026.
Unitech posted a wider Q1 FY27 loss and higher finance costs, while auditors issued a disclaimer citing legacy reconciliation gaps and uncertainty over the company’s going concern status.
The Supreme Court’s 29 July 2026 review order in the Vanashakti case enables OMDC’s delisted Belkundi iron and manganese mine EC proposal to be restored and processed.
Shree Rama Newsprint posted a ₹10.5 crore Q1 FY27 loss as finance costs stayed high, even as operating revenue rose to ₹9.7 crore.
Unitech’s Q1FY27 standalone net loss widened to ₹3,881.9 crore even as revenue rose to ₹658 crore, while auditors issued a disclaimer citing legacy issues and going-concern uncertainty.
Amagi Media Labs reported strong Q1 FY27 growth with profit up 8.6x, revenue up 32.4% and EBITDA turning positive, after board approval on August 13, 2026.
Quadrant Televentures reported Q1FY27 profit of ₹324.80 lakh despite a 7.4% revenue decline, while creditors unanimously backed a 30-day CIRP extension as four plans await voting.
Sakthi Sugars posted 24.6% year-on-year revenue growth for the June 2026 quarter, while the board re-appointed its MD and Joint MD and made key governance appointments.
Saatvik Green Energy disclosed a firm Rs 476 crore solar PV module order from Vikran Engineering, lifting its disclosed order book to Rs 1,500.56 crore with execution by March 2027.
Sakthi Sugars posted 24.6% YoY revenue growth to ₹376.91 crore in Q1 FY27 and announced MD reappointments, director addition, internal audit changes, and AGM date.
Social chatter around Supriya Lifescience focuses on repeated Buy ratings, mixed short-term technical signals, and analyst targets that vary by source despite similar growth assumptions.
India’s pharma stocks slid in 2026 as investors reacted to a US generic-drug tariff timeline, export uncertainty, and Middle East-led shipping disruptions raising freight costs.
Tata Group shares sold off after N Chandrasekaran said he will not seek reappointment in 2027, with reported market-cap erosion led by TCS and Titan.
Integra Essentia posted 42% year-on-year growth in operating revenue for the June 2026 quarter, but net profit fell sharply, alongside a qualified audit observation.
Precision Electronics posted a wider Q1 FY27 loss as operating revenue fell 40% YoY, while the board approved a segment shift to Defence and a proposed Noida asset sale.